These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 22669754)
1. Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up? Cohen Tervaert JW; Damoiseaux J Clin Rev Allergy Immunol; 2012 Dec; 43(3):211-9. PubMed ID: 22669754 [TBL] [Abstract][Full Text] [Related]
2. Testing and reporting antineutrophil cytoplasmic antibodies (ANCA) in treated vasculitis and non-vasculitic disease. Savige J; Trevisin M; Pollock W J Immunol Methods; 2018 Jul; 458():1-7. PubMed ID: 29486145 [TBL] [Abstract][Full Text] [Related]
3. L28. Relevance of detection techniques for ANCA testing. Elena C Presse Med; 2013 Apr; 42(4 Pt 2):582-4. PubMed ID: 23474049 [TBL] [Abstract][Full Text] [Related]
4. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis. Csernok E; Ahlquist D; Ullrich S; Gross WL Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Merkel PA; Polisson RP; Chang Y; Skates SJ; Niles JL Ann Intern Med; 1997 Jun; 126(11):866-73. PubMed ID: 9163287 [TBL] [Abstract][Full Text] [Related]
6. A novel strategy with combined assays for detection of anti-neutrophil cytoplasmic antibody (ANCA) in clinically ANCA-negative granulomatosis with polyangiitis patients. Tateyama K; Kodama S; Kishibe K; Harabuchi Y; Suzuki M Auris Nasus Larynx; 2017 Dec; 44(6):735-741. PubMed ID: 28666565 [TBL] [Abstract][Full Text] [Related]
7. Most proteinase3- and myeloperoxidase-antineutrophil cytoplasmic antibodies enzyme-linked immunosorbent assays perform less well in treated small-vessel vasculitis than in active disease. Savige J; Trevisin M; Hayman M; Pollock W APMIS Suppl; 2009 Jun; (127):60-2. PubMed ID: 19515142 [TBL] [Abstract][Full Text] [Related]
8. Antigen-specific ANCA ELISAs have different sensitivities for active and treated vasculitis and for nonvasculitic disease. Trevisin M; Pollock W; Dimech W; Melny J; Paspaliaris B; Gillis D; Wong R; Savige J Am J Clin Pathol; 2008 Jan; 129(1):42-53. PubMed ID: 18089488 [TBL] [Abstract][Full Text] [Related]
9. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides. Sinclair D; Stevens JM Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028 [TBL] [Abstract][Full Text] [Related]
10. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis. Xin G; Zhao MH; Wang HY Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182 [TBL] [Abstract][Full Text] [Related]
11. Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays. Damoiseaux J; Csernok E; Rasmussen N; Moosig F; van Paassen P; Baslund B; Vermeersch P; Blockmans D; Cohen Tervaert JW; Bossuyt X Ann Rheum Dis; 2017 Apr; 76(4):647-653. PubMed ID: 27481830 [TBL] [Abstract][Full Text] [Related]
12. Antineutrophil cytoplasmic antibody (ANCA) testing of routine sera varies in different laboratories but concordance is greater for cytoplasmic fluorescence (C-ANCA) and myeloperoxidase specificity (MPO-ANCA). Pollock W; Jovanovich S; Savige J J Immunol Methods; 2009 Aug; 347(1-2):19-23. PubMed ID: 19490915 [TBL] [Abstract][Full Text] [Related]
13. A novel high sensitivity ELISA for detection of antineutrophil cytoplasm antibodies against proteinase-3. Hellmich B; Csernok E; Fredenhagen G; Gross WL Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S1-5. PubMed ID: 17428354 [TBL] [Abstract][Full Text] [Related]
14. Comparison of enzyme-linked immunosorbent assay and rapid chemiluminescent analyser in the detection of myeloperoxidase and proteinase 3 autoantibodies. Pucar PA; Hawkins CA; Randall KL; Li C; McNaughton E; Cook MC Pathology; 2017 Jun; 49(4):413-418. PubMed ID: 28549721 [TBL] [Abstract][Full Text] [Related]
15. Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assays. Hagen EC; Andrassy K; Csernok E; Daha MR; Gaskin G; Gross WL; Hansen B; Heigl Z; Hermans J; Jayne D; Kallenberg CG; Lesavre P; Lockwood CM; Lüdemann J; Mascart-Lemone F; Mirapeix E; Pusey CD; Rasmussen N; Sinico RA; Tzioufas A; Wieslander J; Wiik A; Van der Woude FJ J Immunol Methods; 1996 Sep; 196(1):1-15. PubMed ID: 8841439 [TBL] [Abstract][Full Text] [Related]
16. A comparison of commercial and in-house ELISAs for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase. Pollock W; Dunster K; Rolland JM; Koh H; Savige J Pathology; 1999 Feb; 31(1):38-43. PubMed ID: 10212921 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic ANCA algorithms in daily clinical practice: evidence, experience, and effectiveness. Avery TY; Bons J; van Paassen P; Damoiseaux J Lupus; 2016 Jul; 25(8):917-24. PubMed ID: 27252270 [TBL] [Abstract][Full Text] [Related]
18. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Savige J; Gillis D; Benson E; Davies D; Esnault V; Falk RJ; Hagen EC; Jayne D; Jennette JC; Paspaliaris B; Pollock W; Pusey C; Savage CO; Silvestrini R; van der Woude F; Wieslander J; Wiik A Am J Clin Pathol; 1999 Apr; 111(4):507-13. PubMed ID: 10191771 [TBL] [Abstract][Full Text] [Related]
19. Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing. Rao DA; Wei K; Merola JF; O'Brien WR; Takvorian SU; Dellaripa PF; Schur PH J Rheumatol; 2015 May; 42(5):847-52. PubMed ID: 25834211 [TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis. Ruffatti A; Sinico RA; Radice A; Ossi E; Cozzi F; Tonello M; Grypiotis P; Todesco S J Rheumatol; 2002 May; 29(5):918-23. PubMed ID: 12022350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]